Department of Cardiology, Castle Hill Hospital, Hull, UK.
Department of Cardiology, University Hospital of Wales, Cardiff, UK.
Echocardiography. 2020 Nov;37(11):1897-1907. doi: 10.1111/echo.14697. Epub 2020 Jun 30.
Since the E/e' ratio was first described in 1997 as a noninvasive surrogate marker of mean pulmonary capillary wedge pressure, it has gained a central role in diagnostic recommendations and a supremacy in clinical use that require critical reappraisal. We review technical factors, physiological influences, and pathophysiological processes that can complicate the interpretation of E/e'. The index has been validated in certain circumstances, but its use cannot be extrapolated to other situations-such as critically ill patients or children-in which it has either been shown not to work or it has not been well validated. Meta-analyses demonstrated that E/e' is not useful for the diagnosis of HFpEF and that changes in E/e' are uninformative during diastolic stress echocardiography. A similar ratio has been applied to estimate right heart filling pressure despite insufficient evidence. As a composite index, changes in E/e' should only be interpreted with knowledge of changes in its components. Sometimes, e' alone may be as informative. Using a scoring system for diastolic function that relies on E/e', as recommended in consensus documents, leaves some patients unclassified and others in an intermediate category. Alternative methods for estimating left heart filling pressures may be more accurate, including the duration of retrograde pulmonary venous flow, or contractile deformation during atrial pump function. Using all measurements as continuous variables may demonstrate abnormal diastolic function that is missed by using the reductive index E/e' alone. With developments in diagnostic methods and clinical decision support tools, this may become easier to implement.
自 1997 年首次描述 E/e' 比值作为平均肺毛细血管楔压的无创替代标志物以来,它在诊断建议中占据了核心地位,并在临床应用中占据了主导地位,这需要进行批判性重新评估。我们回顾了可能使 E/e' 的解释复杂化的技术因素、生理影响和病理生理过程。该指数在某些情况下得到了验证,但不能将其应用于其他情况,例如危重症患者或儿童,在这些情况下,已经证明该指数不起作用或尚未得到很好的验证。荟萃分析表明,E/e' 对于 HFpEF 的诊断没有帮助,在舒张性超声心动图期间 E/e' 的变化没有信息。尽管证据不足,但类似的比值已被应用于估计右心充盈压。作为一个综合指数,E/e' 的变化只有在了解其组成部分的变化的情况下才能进行解释。有时,仅 e' 可能就具有信息性。使用基于 E/e' 的舒张功能评分系统,如共识文件中建议的那样,会使一些患者无法分类,而另一些患者则处于中间类别。估计左心充盈压的替代方法可能更准确,包括逆行肺静脉血流的持续时间,或心房泵功能期间的收缩变形。使用所有测量值作为连续变量可能会显示出错过使用简化指数 E/e' 所遗漏的异常舒张功能。随着诊断方法和临床决策支持工具的发展,这可能会变得更容易实现。